يعرض 1 - 10 نتائج من 224 نتيجة بحث عن '"Petrini, I"', وقت الاستعلام: 0.88s تنقيح النتائج
  1. 1
    دورية أكاديمية
    Increased production of inflammatory cytokines by circulating monocytes in mesial temporal lobe epilepsy: A possible role in drug resistance

    المؤلفون: Milano, C, Montali, M, Barachini, S, Burzi, I S, Pratesi, F, Petrozzi, L, Chico, L, Morganti, R, Gambino, G, Rossi, L, Ceravolo, R, Siciliano, G, Migliorini, P, Petrini, I, Pizzanelli, C

    المساهمون: Milano, C, Montali, M, Barachini, S, Burzi, I S, Pratesi, F, Petrozzi, L, Chico, L, Morganti, R, Gambino, G, Rossi, L, Ceravolo, R, Siciliano, G, Migliorini, P, Petrini, I, Pizzanelli, C

    مصطلحات موضوعية: Cytokine, Drug-resistant epilepsy, Mesial temporal lobe epilepsy, Neuroinflammation, Oxidative stre, Peripheral blood mononuclear cells

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/38160122; info:eu-repo/semantics/altIdentifier/wos/WOS:001161658100001; volume:386; numberofpages:11; journal:JOURNAL OF NEUROIMMUNOLOGY; https://hdl.handle.net/11568/1219367Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85181079986; https://www.jni-journal.com/article/S0165-5728Test(23)00258-8/fulltext

    الإتاحة: https://doi.org/10.1016/j.jneuroim.2023.578272Test
    https://hdl.handle.net/11568/1219367Test
    https://www.jni-journal.com/article/S0165-5728Test(23)00258-8/fulltext

    View record in BASE

    أضف إلى المفضلة
  2. 2
    دورية أكاديمية
    Amivantamab in the Treatment of Metastatic NSCLC: Patient Selection and Special Considerations

    المؤلفون: Petrini I, Giaccone G

    المصدر: OncoTargets and Therapy, Vol Volume 15, Pp 1197-1210 (2022)

    مصطلحات موضوعية: amivantamab, exon 20 insertion of egfr, nsclc, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

    وصف الملف: electronic resource

    العلاقة: https://www.dovepress.com/amivantamab-in-the-treatment-of-metastatic-nsclc-patient-selection-and-peer-reviewed-fulltext-article-OTTTest; https://doaj.org/toc/1178-6930Test

    الوصول الحر: https://doaj.org/article/82d88442f3d842e099f72f4b467108e9Test

    View record in DOAJ النص الكامل

    أضف إلى المفضلة
  3. 3
    دورية أكاديمية
    Somatic mutations of thymic epithelial tumors with myasthenia gravis

    المؤلفون: Pardini E., Cucchiara F., Palumbo S., Tarrini G., Di Vita A., Coppede F., Nicoli V., Guida M., Maestri M., Ricciardi R., Aprile V., Ambrogi M. C., Barachini S., Lucchi M., Petrini I.

    المساهمون: Pardini, E., Cucchiara, F., Palumbo, S., Tarrini, G., Di Vita, A., Coppede, F., Nicoli, V., Guida, M., Maestri, M., Ricciardi, R., Aprile, V., Ambrogi, M. C., Barachini, S., Lucchi, M., Petrini, I.

    مصطلحات موضوعية: GTF2I, myasthenia gravi, next-generation sequencing, thymic epithelial tumor, thymoma

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/37671056; info:eu-repo/semantics/altIdentifier/wos/WOS:001057659100001; volume:13; numberofpages:12; journal:FRONTIERS IN ONCOLOGY; https://hdl.handle.net/11568/1206387Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85169692262; https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2023.1224491/fullTest

    الإتاحة: https://doi.org/10.3389/fonc.2023.1224491Test
    https://hdl.handle.net/11568/1206387Test

    View record in BASE

    أضف إلى المفضلة
  4. 4
    دورية أكاديمية
    Isolation and characterization of two newly established thymoma PDXs from two relapses of the same patient: a new tool to investigate thymic malignancies

    المؤلفون: Mendogni P, Affatato R, Cabri E, Chiappa M, Ndembe G, Tosi D, Del Gobbo A, Fratelli M, Pardini E, Petrini I, Rosso L, MASSIMO BROGGINI, Marabese M

    المساهمون: Mendogni, P, Affatato, R, Cabri, E, Chiappa, M, Ndembe, G, Tosi, D, Del Gobbo, A, Fratelli, M, Pardini, E, Petrini, I, Rosso, L, Massimo, Broggini, Marabese, M

    مصطلحات موضوعية: Patient-derived xenograft, Pre-clinical model, Thymoma

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/36517829; info:eu-repo/semantics/altIdentifier/wos/WOS:000899203500002; volume:41; issue:1; numberofpages:6; journal:JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH; https://hdl.handle.net/11568/1161990Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85144321988; https://jeccr.biomedcentral.com/articles/10.1186/s13046-022-02554-4Test

    الإتاحة: https://doi.org/10.1186/s13046-022-02554-4Test
    https://hdl.handle.net/11568/1161990Test

    View record in BASE

    أضف إلى المفضلة
  5. 5
    دورية أكاديمية
    Defining TCRγδ lymphoproliferative disorders by combined immunophenotypic and molecular evaluation

    المؤلفون: Teramo A., Binatti A., Ciabatti E., Schiavoni G., Tarrini G., Barila G., Calabretto G., Vicenzetto C., Gasparini V. R., Facco M., Petrini I., Grossi R., Pisanti N., Bortoluzzi S., Falini B., Tiacci E., Galimberti S., Semenzato G., Zambello R.

    المساهمون: Teramo, A., Binatti, A., Ciabatti, E., Schiavoni, G., Tarrini, G., Barila, G., Calabretto, G., Vicenzetto, C., Gasparini, V. R., Facco, M., Petrini, I., Grossi, R., Pisanti, N., Bortoluzzi, S., Falini, B., Tiacci, E., Galimberti, S., Semenzato, G., Zambello, R.

    مصطلحات موضوعية: Human, Immunophenotyping, Mutation, Phenotype, Leukemia, Large Granular Lymphocytic, Receptors, Antigen, T-Cell, gamma-delta

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/35676278; info:eu-repo/semantics/altIdentifier/wos/WOS:000809119000003; volume:13; issue:1; firstpage:3298; journal:NATURE COMMUNICATIONS; https://hdl.handle.net/11568/1149765Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85131658093

    الإتاحة: https://doi.org/10.1038/s41467-022-31015-xTest
    https://hdl.handle.net/11568/1149765Test

    View record in BASE

    أضف إلى المفضلة
  6. 6
    دورية أكاديمية
    ED-B-Containing Isoform of Fibronectin in Tumor Microenvironment of Thymomas: A Target for a Theragnostic Approach

    المؤلفون: Petrini I., Sollini M., Bartoli F., Barachini S., Montali M., Pardini E., Burzi I. S., Erba P. A.

    المساهمون: Petrini, I, Sollini, M, Bartoli, F, Barachini, S, Montali, M, Pardini, E, Burzi, I, Erba, P

    مصطلحات موضوعية: fibronectin, target therapy, theragnostic, thymic epithelial tumor, tumor microenvironment

    وصف الملف: ELETTRONICO

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/35681572; info:eu-repo/semantics/altIdentifier/wos/WOS:000808601400001; volume:14; issue:11; journal:CANCERS; https://hdl.handle.net/10281/419518Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85130997481

    الإتاحة: https://doi.org/10.3390/cancers14112592Test
    https://hdl.handle.net/10281/419518Test

    View record in BASE

    أضف إلى المفضلة
  7. 7
    دورية أكاديمية
    Efficacy and safety of ramucirumab plus carboplatin and paclitaxel in untreated metastatic thymic carcinoma: RELEVENT phase II trial (NCT03921671).

    المؤلفون: Proto, C, Ganzinelli, M, Manglaviti, S, Imbimbo, M, Galli, G, Marabese, M, Zollo, F, Alvisi, M F, Perrino, M, Cordua, N, Borea, F, de Vincenzo, F, Chella, A, Cappelli, S, Pardini, E, Ballatore, Z, Lucarelli, A, Ambrosini, E, Giuliano, M, Pietroluongo, E, Mulargiu, C, Fabbri, A, Prelaj, A, Occhipinti, M, Brambilla, M, Mazzeo, L, Beninato, T, Vigorito, R, Ruggirello, M, Greco, F G, Calareso, G, Miliziano, D, Rulli, E, De Simone, I, Torri, V, de Braud, F G M, Pasello, G, De Placido, P, Berardi, R, Petrini, I, Zucali, P, Garassino, M C, Lo Russo, G

    المصدر: Ann Oncol ; ISSN:1569-8041

    مصطلحات موضوعية: antiangiogenics, chemotherapy, first line, ramucirumab, thymic carcinoma

    العلاقة: https://doi.org/10.1016/j.annonc.2024.06.002Test; https://pubmed.ncbi.nlm.nih.gov/38857846Test

    الإتاحة: https://doi.org/10.1016/j.annonc.2024.06.002Test
    https://pubmed.ncbi.nlm.nih.gov/38857846Test

    View record in BASE

    أضف إلى المفضلة
  8. 8
    دورية أكاديمية
    364P Tepotinib with an EGFR-tyrosine kinase inhibitor (TKI) in patients with EGFR-mutant MET-amplified NSCLC: A case series

    المؤلفون: Ahmad, A.R., Tho, L.M., Chik, Y.K.J., Lee, W.C.K., Yang, T-Y., Le, X., Eisert, A.K., Himpe, U., De Bondt, C., Mazieres, J., Petrini, I., Lam, W-S., Joshi, K., Berghoff, K., Vlassak, S., Karachaliou, N., Van Der Wekken, A.J., Hsia, T-C.

    المصدر: Annals of Oncology ; volume 33, page S1584 ; ISSN 0923-7534

    مصطلحات موضوعية: Oncology, Hematology

    الإتاحة: https://doi.org/10.1016/j.annonc.2022.10.402Test
    https://api.elsevier.com/content/article/PII:S0923753422045938?httpAccept=text/xmlTest
    https://api.elsevier.com/content/article/PII:S0923753422045938?httpAccept=text/plainTest

    View record in BASE

    أضف إلى المفضلة
  9. 9
    دورية أكاديمية
    1069P An immune-based score for the prediction of clinical outcome in patients with metastatic non-small cell lung cancer treated with first-line immunotherapy

    المؤلفون: Sbrana, A., Cappelli, S., Petrini, I., Chella, A., Carrozzi, L.

    المصدر: Annals of Oncology ; volume 33, page S1042 ; ISSN 0923-7534

    مصطلحات موضوعية: Oncology, Hematology

    الإتاحة: https://doi.org/10.1016/j.annonc.2022.07.1195Test
    https://api.elsevier.com/content/article/PII:S0923753422030460?httpAccept=text/xmlTest
    https://api.elsevier.com/content/article/PII:S0923753422030460?httpAccept=text/plainTest

    View record in BASE

    أضف إلى المفضلة
  10. 10
    دورية أكاديمية
    EP08.02-162 Tepotinib with an EGFR-Tyrosine Kinase Inhibitor (TKI) in Patients with EGFR-mutant MET-amplified NSCLC: A Case Series

    المؤلفون: Le, X., Eisert, A., Himpe, U., De Bondt, C., Mazieres, J., Petrini, I., Tho, L.M., Ahmad, A., Lam, W.-S., Chik, Y.K.J., Lee, W.C.K., Yang, T.-Y., Joshi, K., Berghoff, K., Vlassak, S., Karachaliou, N., Wekken, A.v.d.

    المصدر: Journal of Thoracic Oncology ; volume 17, issue 9, page S483-S484 ; ISSN 1556-0864

    مصطلحات موضوعية: Pulmonary and Respiratory Medicine, Oncology

    الإتاحة: https://doi.org/10.1016/j.jtho.2022.07.845Test
    https://api.elsevier.com/content/article/PII:S1556086422011868?httpAccept=text/xmlTest
    https://api.elsevier.com/content/article/PII:S1556086422011868?httpAccept=text/plainTest

    View record in BASE

    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث